Target intelligence / Profile preview

FBXO3 divergent transcript (FBXO3-DT)

Target
FBXO3-DT
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

FBXO3-DT (FBXO3 divergent transcript), also known as LINC02722, is a long non-coding RNA transcript located near the FBXO3 gene locus. There is currently no known evidence that this RNA serves as a drug target, biomarker, or has any characterized molecular or disease function. It should not be confused with FBXO3, which is a protein-coding gene involved in ubiquitin-mediated protein degradation and regulation of inflammation, immunity, cellular apoptosis, and neuropathic pain[1][3].

Other names
LINC02722FBXO3 divergent transcript
02

Biological functions

Unknown; as an lncRNA, potential regulatory roles on gene expression are possible, but specific functions of FBXO3-DT/LINC02722 are uncharacterized in available literature.
03

Disease associations

Unknown. There are currently no well-supported roles for this transcript in cancer, inflammation, neurodegenerative, or other diseases in current literature or public gene annotation resources.

Beyond the preview

Go deeper on FBXO3 divergent transcript (FBXO3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FBXO3 divergent transcript (FBXO3-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call